Cited by 2,834Antibiotic Resistance in BacteriaAntibiotic Use and ResistanceAntimicrobial Resistance in Staphylococcus

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.

The Crisis in Antibiotic Resistance

Neu, Harold C.·1992·Science

Open this paper in CoChat — free account

Abstract

The synthesis of large numbers of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of the exchange of genetic material via plasmids and transposons. Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics. The extensive use of antibiotics in the community and hospitals has fueled this crisis. Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.

Integrity signals

Registry

Crossref · 10.1126/science.257.5073.1064

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,887
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 887
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 804
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 776
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 704
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA
Bugg, T. D. H., Wright, G. D., Dutka‐Malen, S., Arthur, M., Courvalin, P. M., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 642
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 629
Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.
McMurry, L. M., Petrucci, R., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 606
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mr.51.1.88-134.1987 · Cited by 593

Show all 109 references

Research works printed but not linked: 30

AMERICAN JOURNAL OF MEDICINE 91 3B (1991).
APPELBAUM, P. C., EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 367 (1987).
BANERJEE, S.N., SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989, AMERICAN JOURNAL OF MEDICINE 91: S86 (1991).
BOYCE, J. M., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 249: 2803 (1983). · DOI
Bryan, L. E., Antimicrobial Drug Resistance 241 (1984).
BUOHO, A. Y., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 B: 41 (1988).
BUSH, K, ANTIMICROB AGENTS CH 33: 339 (1989).
COOKSON, B. D., JOURNAL OF APPLIED BACTERIOLOGY 69: 55S (1990).
DEGUCHI, K, JAPANESE JOURNAL OF ANTIBIOTICS 42: 2133 (1990).
Fisher, M., New Antibacterial Strategies 177 (1990).
Higgins, C. F., New Antibacterial Strategies 193 (1990).
KHARDORI, N, REVIEWS OF INFECTIOUS DISEASES 12: 996 (1990).
LUJAN, R, REVISTA ESPANOLA DE QUIMIOTERAPIA 3: 323 (1990).
McMurry, L., Proceedings of the National Academy of Sciences of the United States of America 77: 3974 (1980).
MILATOVIC, D, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 234 (1987).
Mitsuhashi, S., The Aminoglycosides 97 (1982).
MOELLERING, R, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 28: 1 (1991).
MUDDER, R.R., ARCH INTERN MED 147: 1672 (1987). · DOI
NEU, H. C., AMERICAN JOURNAL OF MEDICINE 76: 11 (1984).
NEU, H.C., AMERICAN JOURNAL OF MEDICINE 7 5A: 2 (1985).
Neu, H. C., Human Pharmacology 613 (1991).
Normark, S., New Antibacterial Strategies 161 (1990).
PHILLIPS, I, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 27: 40 (1991).
SCHABERG, D. R., AMERICAN JOURNAL OF MEDICINE 91 3B: 725 (1991).
SKURRAY, R. A., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 21 C: 19 (1988).
SLOCOMBE, B,JOURNAL OF HOSPITAL INFECTION 19: 19 (1991).
SMITH, A, INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 5: 177 (1992).
TALLY, F. P., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 A: 63 (1989).
TENOVER, F. C., AMERICAN JOURNAL OF MEDICINE 91: S76 (1991).
UTTLEY, AHC, VANCOMYCIN-RESISTANT ENTEROCOCCI, LANCET 1: 57 (1988).

Sorted by citations

Items 801–900 of 1,000

Molecular mechanisms of bacterial resistance to antimicrobial agents
Kumar, S. H., & Varela, M. F. (2013) · Cited by 50
Can biotech deliver new antibiotics?
Barrett, J. F. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.007 · Cited by 50
“It is only within the past decade that the increasingly serious nature of resistance has been recognized [5,13–16], and consensus has emerged that it is essential that novel antibiotic classes are developed as part of the strategy to control the emerging drug-resistant pathogens [17–19].”
Inappropriate Use of Antibiotics and the Risk for Delayed Admission and Masked Diagnosis of Infectious Diseases
Liu, Y.-C., Huang, W.-K., Huang, T.-S., & Kunin, C. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.19.2366 · Cited by 50
“The shortcomings of this study include the inability (1) to detect prior use of antimicrobial drugs for more than 1 or 2 days before arrival in the ED or drugs that are not excreted in the urine, (2) to determine the outcome for patients who were discharged from the ED, and (3) to assess the potential benefits and def…”
Cloning and characterization of a novel, plasmid-encoded trimethoprim-resistant dihydrofolate reductase from Staphylococcus haemolyticus MUR313
Dale, G. E., Langen, H., Page, M. G. P., Then, R. L., & Stüber, D. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1920 · Cited by 50
“Of particular interest is methicillin-resistant Staphylococcus aureus (MRSA), which invariably carries genes for resistance to other antibiotics such as erythromycin, tetracycline, streptomycin, gentamicin, and sulfonamides (27).”
Background
Modeling and simulating the evolution of resistance against antibiotics
Massad, E., Lundberg, S., & Yang, H. M. (1993) · International Journal of Bio-Medical Computing · doi:10.1016/0020-7101(93)90060-j · Cited by 50
Bacterial Peptidoglycan Biosynthesis and its Inhibition
Bugg, T. D. H. (1999) · Elsevier eBooks · doi:10.1016/b978-0-08-091283-7.00080-1 · Cited by 50
Operando Investigation of Locally Enhanced Electric Field Treatment (LEEFT) Harnessing Lightning-Rod Effect for Rapid Bacteria Inactivation
Wang, T., Brown, D. K., & Xie, X. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c02240 · Cited by 49
Antimicrobial compounds from mangrove plants: A pharmaceutical prospective
Patra, J. K., & Mohanta, Y. K. (2014) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-014-1747-0 · Cited by 49
Chronic Infectious Disease and the Future of Health Care Delivery
Farmer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1310472 · Cited by 50
Reduction of Urease Activity by Interaction with the Flap Covering the Active Site
Macomber, L., Minkara, M. S., Hausinger, R. P., & Merz, K. M. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500562t · Cited by 49
A Community Intervention to Decrease Antibiotics Used for Self-Medication Among Latino Adults
Mainous, A. G., Díaz, V. A., & Carnemolla, M. A. (2009) · The Annals of Family Medicine · doi:10.1370/afm.1061 · Cited by 49
Multi-scale strategy to eradicate Pseudomonas aeruginosa on surfaces using solid lipid nanoparticles loaded with free fatty acids
Taylor, E. N., Kummer, K. M., Dyondi, D., Webster, T. J., & Banerjee, R. (2013) · Nanoscale · doi:10.1039/c3nr04270g · Cited by 50
Reactive combinatorial synthesis and characterization of a gradient Ag–Ti oxide thin film with antibacterial properties
Unosson, E., Rius, D. R., Welch, K., & Engqvist, H. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.09.048 · Cited by 49
“The over use of antibiotics and increased antibiotic resistance from pathogens is considered one of the most concerning health threats of the 21st century, and new technologies addressing the issue are desperately needed [9-11,32-34].”
Background
The Development of Cooperative Associations Between Animals and Bacteria: Establishing Détente Among Domains
McFall‐Ngai, M. (1998) · American Zoologist · doi:10.1093/icb/38.4.593 · Cited by 49
“Unfortunately, during this early phase of antibiotic development, the plasticity of the bacterial genome was not appreciated, and now bacterial pathogens with multiple antibiotic resistances have arisen and present a threat as never before (Cohen, 1992; Neu, 1992).”
Background
Implications of lipid monolayer charge characteristics on their selective interactions with a short antimicrobial peptide
Ciumac, D., Campbell, R. A., Xu, H., Clifton, L. A., Hughes, A. V., Webster, J. R. P., & Lu, J. R. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.10.043 · Cited by 49
Vancomycin-modified Fe3O4@SiO2@Ag microflowers as effective antimicrobial agents
Wang, C., Zhang, K., Zhou, Z., Li, Q., Shao, L., Hao, R. Z., Xiao, R., & Wang, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132570 · Cited by 49
“health care; this condition decreases the efficiency of conventional antibiotics and significantly increases the number of clinical infections.(1,2) In this regard, scholars”
Nanotechnological solutions for controlling transmission and emergence of antimicrobial-resistant bacteria, future prospects, and challenges: a systematic review
Ssekatawa, K., Byarugaba, D. K., Kato, C. D., Ejobi, F., Tweyongyere, R., Lubwama, M., Kirabira, J. B., & Wampande, E. M. (2020) · Journal of Nanoparticle Research · doi:10.1007/s11051-020-04817-7 · Cited by 49
“…gene that transcribes for a single supplementary penicillin-binding protein, PBP2a with low affinity for all β-lactams Stapleton and Taylor 2002, Neu 1992; Spratt 1994 Hydrolytic enzyme-mediated antibiotic resistance Main molecular mechanism of resistance is through acquisition of chromosomal…”
Background
Upgrading antibiotic use within a class: Tradeoff between resistance and treatment success
Wang, Y. C., & Lipsitch, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600636103 · Cited by 49
Development of a clindamycin-impregnated fiber as an intracanal medication in endodontic therapy
Gilad, J. Z., Teles, R. P., Goodson, M., White, R. R., & Stashenko, P. (1999) · Journal of Endodontics · doi:10.1016/s0099-2399(99)80117-4 · Cited by 49
Multidrug efflux systems in Gram-negative bacteria
Moreira, M. A. S., de Souza, E. C., & de Moraes, C. A. (2004) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822004000100003 · Cited by 47
“Throughout their evolution, microorganisms have developed versatile resistance mechanisms to toxic effects of antibiotics as well as other drugs (28,69).”
Background
Inhibition of the NMC-A β-Lactamase by a Penicillanic Acid Derivative and the Structural Bases for the Increase in Substrate Profile of This Antibiotic Resistance Enzyme
Mourey, L., Miyashita, K., Swarén, P., Bulychev, A., Samama, J., & Mobashery, S. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9817996 · Cited by 49
Site-Directed Mutagenesis of Glutamate-166 in .beta.-Lactamase Leads to a Branched Path Mechanism
Escobar, W. A., Tan, A. K., Lewis, E. R., & Fink, A. L. (1994) · Biochemistry · doi:10.1021/bi00190a015 · Cited by 49
Multidrug and vancomycin resistance among clinical isolates of Staphylococcus aureus from different teaching hospitals in Nigeria
Olajuyigbe, O. O., Tolulope, I., & Roger, C. (2017) · African Health Sciences · doi:10.4314/ahs.v17i3.23 · Cited by 48
“(20)10% of the isolates were vancomycin intermediate resistant S.”
Background
Short communication: carboxylate functionalized superparamagnetic iron oxide nanoparticles (SPION) for the reduction of S. aureus growth post biofilm formation
Webster, T. J., Leuba, K., Durmus, & Taylor (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s38256 · Cited by 48
Failure of antibiotic treatment in microbial populations
Leenheer, P. D., & Cogan, N. G. (2008) · Journal of Mathematical Biology · doi:10.1007/s00285-008-0243-6 · Cited by 48
“Although there is evidence that the over use of antibiotics has amplified the number of chromosomal-resistant bacteria [18], it is becoming increasingly clear that there are other mechanisms that protect populations of bacteria.”
Background
The Chinese bamboo leaf odorous frog (Rana (Odorrana) versabilis) and North American Rana frogs share the same families of skin antimicrobial peptides
Chen, T., Zhou, M., Rao, P., Walker, B., & Shaw, C. (2006) · Peptides · doi:10.1016/j.peptides.2006.02.009 · Cited by 48
Does Adherence to the Loeb Minimum Criteria Reduce Antibiotic Prescribing Rates in Nursing Homes?
Olsho, L. E. W., Bertrand, R. M., Edwards, A. S., Hadden, L. S., Morefield, G. B., Hurd, D. T., Mitchell, C. M., Sloane, P. D., & Zimmerman, S. I. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.01.002 · Cited by 48
Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps
Tintino, S. R., Oliveira–Tintino, C. D. D. M., Campina, F. F., Pereira, R. L. S., Costa, M. D. S., Morais‐Braga, M. F. B., Limaverde, P. W., Andrade, J. C., Siqueira-Júnior, J. P., Coutinho, H. D. M., et al. (2016) · EXCLI journal · doi:10.17179/excli2016-277 · Cited by 48
“The active efflux of substances that inhibit bacterial growth such as toxic compounds and antibiotics, in S. aureus, is mediated by integral membrane transporters, known as drug efflux pumps (Levy, 1992).”
Background
Recent progress in the optical detection of pathogenic bacteria based on noble metal nanoparticles
Yang, S., Liu, Q.-A., Liu, Y., Weng, G., Zhu, J. R., & Li, J.-J. (2021) · Microchimica Acta · doi:10.1007/s00604-021-04885-z · Cited by 48
Experimental studies on the ecological role of antibiotic production in bacteria
Wiener, P. (1996) · Evolutionary Ecology · doi:10.1007/bf01237726 · Cited by 48
“The recent problem of antibiotic-resistant human pathogens highlights the fact that strong selection pressures from clinical use of antibiotics in conjunction with short generation times allow microorganisms to evolve resistance rapidly (Cohen, 1992, 1994; Neu, 1992).”
Background
Der Aufbau von Vancomycin: so macht es die Natur
Hubbard, B. K., & Walsh, C. T. (2003) · Angewandte Chemie · doi:10.1002/ange.200390171 · Cited by 48
β-Lactam antibiotics, β-lactamases and bacterial resistance
Kotra, L. P., & Mobashery, S. (1998) · Bulletin de l Institut Pasteur · doi:10.1016/s0020-2452(98)80009-2 · Cited by 49
Confronting Multidrug Resistance
Levy, S. B. (1993) · JAMA · doi:10.1001/jama.1993.03500140092042 · Cited by 48
The Population Genetics of Antibiotic Resistance II: Analytic Theory for Sustained Populations of Bacteria in a Community of Hosts
Stewart, F. M., Antia, R., Levin, B. R., Lipsitch, M., & Mittler, J. E. (1998) · Theoretical Population Biology · doi:10.1006/tpbi.1997.1352 · Cited by 48
“Now, however, the prognosis is substantially more dreary; ``natural'' selection appears to be winning the arms race with technology (Neu, 1992).”
Background
AUIC — The Universal Parameter within the Constraint of a Reasonable Dosing Interval
Schentag, J. J., Nix, D. E., Forrest, A., & Adelman, M. H. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000920 · Cited by 48
Metal nanoparticles assisted revival of Streptomycin against MDRS Staphylococcus aureus
Ghaffar, N., Javad, S., Farrukh, M. A., Shah, A. A., Gatasheh, M. K., ALMunqedhi, B. M. A., & Chaudhry, O. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264588 · Cited by 47
Development of Wash-Durable Antimicrobial Cotton Fabrics by In Situ Green Synthesis of Silver Nanoparticles and Investigation of Their Antimicrobial Efficacy against Drug-Resistant Bacteria
Jain, A., Kongkham, B., Hariprasad, P., Butola, B. S., Malik, H. K., & Malik, A. (2022) · Antibiotics · doi:10.3390/antibiotics11070864 · Cited by 50
“The bacteria have developed resistance to antibiotics by altering the target of the antibiotics, making them ineffective [3].”
Background
Endogenous oxygen-evolving bio-catalytic fabrics with fortified photonic disinfection for invasive bacteria-caused refractory cutaneous regeneration
Wang, Z., Du, B., Gao, X., Huang, Y., Li, M., Yu, Z., Li, J., Shi, X., Deng, Y., & Liang, K. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101595 · Cited by 49
Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs
White, D. G., Maneewannakul, K., Hofe, E. V., Zillman, M. A., Eisenberg, W., Field, A., & Levy, S. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.12.2699 · Cited by 47
“Drug resistance has emerged as a serious medical problem in both hospitals and the community, leading to increasing morbidity and mortality (25).”
Background
Relationship between structure and antibacterial activity of lipophilic N-acyldiamines
de Almeida, C. G., Garbois, G. D., Amaral, L. M., Diniz, C. G., & Hyaric, M. L. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.09.013 · Cited by 47
“This resistance is actually a major health problem, resulting in an urgent need for new antibacterial compounds [1–3].”
Background
Recyclable Escherichia coli-Specific-Killing AuNP–Polymer (ESKAP) Nanocomposites
Yuan, Y., Liu, F., Xue, L., Wang, H., Pan, J., Cui, Y., Chen, H., & Yuan, L. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02074 · Cited by 47
Toward a dynamic theory of antibiotic resistance
Homer, J. B., Ritchie‐Dunham, J. L., Rabbino, H., Puente, L. M., Jorgensen, J. H., & Hendricks, K. (2000) · System Dynamics Review · doi:10.1002/sdr.200 · Cited by 47
Survey of antibiotic-resistant bacteria isolated from bottlenose dolphins Tursiops truncatus in the southeastern USA
Stewart, J. R., Townsend, F., Lane, S., Dyar, E., Hohn, A. A., Rowles, T., Staggs, L., Wells, R., Balmer, B. C., & Schwacke, L. H. (2013) · Diseases of Aquatic Organisms · doi:10.3354/dao02705 · Cited by 49
Bacterial resistance mechanisms as therapeutic targets
Coleman, K., Athalye, M., Clancey, A., Davison, M., Payne, D. J., Perry, C., & Chopra, I. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.6.1091 · Cited by 47
Development of Penicillin Resistance among Staphylococcus aureus Isolated from Bovine Mastitis in Denmark and Other Countries
Aarestrup, F. M., & Jensen, N. E. (1998) · Microbial Drug Resistance · doi:10.1089/mdr.1998.4.247 · Cited by 47
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Morita, M. M. (1993) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02891-2 · Cited by 47
Crystal structure of the tet repressor in complex with a novel tetracycline, 9-( N , N -dimethylglycylamido)-6-demethyl-6-deoxy-tetracycline 1 1Edited by R. Huber
Orth, P., Schnappinger, D., Sum, P., Ellestad, G. A., Hillen, W., Saenger, W., & Hinrichs, W. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2290 · Cited by 47
Plasmonic nano-antimicrobials: properties, mechanisms and applications in microbe inactivation and sensing
An, X., Erramilli, S., & Reinhard, B. M. (2021) · Nanoscale · doi:10.1039/d0nr08353d · Cited by 48
Cationic Antimicrobial Peptides Are Leading the Way to Combat Oropathogenic Infections
Lin, B., Li, R., Handley, T. N. G., Wade, J. D., Li, W., & O’brien-simpson, N. M. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00424 · Cited by 46
Incorporation of Penicillin‐Producing Fungi into Living Materials to Provide Chemically Active and Antibiotic‐Releasing Surfaces
Gerber, L. C., Koehler, F. M., Grass, R. N., & Stark, W. J. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204337 · Cited by 48
QSAR modeling of the antimicrobial activity of peptides as a mathematical function of a sequence of amino acids
Toropova, M. A., Veselinović, A. M., Veselinović, J. B., Stojanović, D. B., & Toropov, A. A. (2015) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2015.09.009 · Cited by 46
An electrochemical lipopolysaccharide sensor based on an immobilized Toll-Like Receptor-4
Mayall, R. M., Renaud-Young, M. M., Chan, N. W. C., & Birss, V. I. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.09.009 · Cited by 46
In vivo osseointegration of dental implants with an antimicrobial peptide coating
Chen, X., Zhou, X. C., Liu, S., Wu, R., Aparicio, C., & Wu, J. (2017) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-017-5885-8 · Cited by 46
“to be effective, their use is controversial because of their potential host cytotoxicity and bacterial resistance [21].”
Background
Assessment of antibiotic use in farm animals in Rwanda
Manishimwe, R., Nishimwe, K., & Ojok, L. (2017) · Tropical Animal Health and Production · doi:10.1007/s11250-017-1290-z · Cited by 46
Self-immolative polymers with potent and selective antibacterial activity by hydrophilic side chain grafting
Ergene, C., & Palermo, E. F. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01632a · Cited by 46
Antibiotic resistance versus small molecules, the chemical evolution
LEE, V. J., & Hecker, S. J. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199911)19:6 · Cited by 46
Mutant Prevention Concentration of Garenoxacin (BMS-284756) for Ciprofloxacin-Susceptible or -Resistant Staphylococcus aureus
Zhao, X., Eisner, W., Perl-Rosenthal, N., Kreiswirth, B. N., & Drlica, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1023-1027.2003 · Cited by 46
“Unfortunately, Staphylococcus aureus readily develops resistance to derivatives such as ciprofloxacin (1, 3, 18).”
Background
Lipid-Layer Crystallization and Preliminary Three-Dimensional Structural Analysis of AcrA, the Periplasmic Component of a Bacterial Multidrug Efflux Pump
Avila-Sakar, A., Misaghi, S., Kubalek, E. W., Downing, K. H., Zgurskaya, H. I., Nikaido, H., & Nogales, E. (2001) · Journal of Structural Biology · doi:10.1006/jsbi.2001.4418 · Cited by 46
Rapid identification of metallo- and serine beta-lactamases
Payne, D. J., Cramp, R., Bateson, J. H., NEALE, J. E., & KNOWLES, D. J. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.991 · Cited by 46
Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods
Gonzales, R., Bartlett, J. G., Besser, R. E., Cooper, R. J., Hickner, J. M., Hoffman, J. R., & Sande, M. A. (2001) · Annals of Emergency Medicine · doi:10.1067/s0196-0644(01)70087-x · Cited by 45
Mechanism study of SO 2 elimination from sulfonamides by negative electrospray ionization mass spectrometry
Hu, N., Liu, P., Jiang, K., Zhou, Y., & Pan, Y. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3672 · Cited by 45
Antimicrobial activity of β-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance
Athanassiou, G. C., Michaleas, S., Lada-Chitiroglou, E., Tsitsa, T., & Antoniadou‐Vyza, E. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702649 · Cited by 45
“Despite this, the successful treatment of nosocomial infections still remains a serious problem (Neu 1992; Ash 1996).”
Background
Differential Mechanism of Escherichia coli Inactivation by (+)-Limonene as a Function of Cell Physiological State and Drug's Concentration
Chueca, B., Pagán, R., & García‐Gonzalo, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094072 · Cited by 45
“occurrence of bacterial resistance to antibiotics [2] is stimulating the pharmaceutical industry to search for alternative antimicrobials.”
Background
Identification of Functional Differences in Metabolic Networks Using Comparative Genomics and Constraint-Based Models
Hamilton, J. J., & Reed, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034670 · Cited by 46
“It is believed that the use of such antibiotics can overcome multi-drug resistance through novel mechanisms of action [32,33] and slow the rate of resistance transfer across species [31,34].”
Background
Molecular Mechanism of Drug Resistance
Ray, S., Das, S., & Suar, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_3 · Cited by 51
“This has also led the researchers to investigate into the pathogen’s clinical, molecular, and cellular factors that make them the superbugs of resistance (Arnold 2007; Neu 1992).”
Background
Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics
Andersson, J. A., Sha, J., Kirtley, M. L., Reyes, E., Fitts, E. C., Dann, S. M., & Chopra, A. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01943-17 · Cited by 45
Molecular viability testing of viable but non‐culturable bacteria induced by antibiotic exposure
Lee, S., & Bae, S. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.13039 · Cited by 45
“tein synthesis inhibition by targeting to the 30S ribosomal (Neu, 1992; McManus, 1997), but levofloxacin is a quino-”
Background
Synbiotic as eco-friendly feed additive in diets of chickens under hot climatic conditions
Abdel‐Wareth, A. A. A., Hammad, S., Khalaphallah, R., Salem, W., & Lohakare, J. (2019) · Poultry Science · doi:10.3382/ps/pez115 · Cited by 45
Photodynamic inactivation of Escherichia coli by Ru(II) complexes
Lei, W., Zhou, Q., Jiang, G., Zhang, B., & Wang, X. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00275e · Cited by 45
Shortcut to Mycothiol Analogues
Knapp, S., González, S., Myers, D. S., Eckman, L. L., & Bewley, C. A. (2002) · Organic Letters · doi:10.1021/ol0269796 · Cited by 45
Immunization with aPseudomonas aeruginosa1244 Pilin Provides O-Antigen-Specific Protection
Horzempa, J., Held, T. K., Cross, A. S., Furst, D., Qutyan, M., Neely, A. N., & Castric, P. A. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00476-07 · Cited by 45
“With the widespread occurrence of antibiotic resistance among many bacterial pathogens (29, 33, 47), it is increasingly necessary to turn to vaccination to combat these disease-causing organisms.”
Background
Phage Therapy: Emergent Property Pharmacology
Abedon, A. J. C. S. T. (2012) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.s6-002 · Cited by 45
“More generally, bacteria are able to evolve various biofilm-independent mechanisms of antibacterial resistance including those resulting from horizontal gene transfer [13,25].”
Background
Better Control of Antibiotic Resistance
Guillemot, D., & Courvalin, P. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322583 · Cited by 45
“Since the appearance of various publications on the alarming aspects of resistance, which echoed widely in the media [54, 55], the scientific and medical communities have become mobilized [1, 56].”
Background
Crystal Structure of Type II Peptide Deformylase from Staphylococcus aureus
Baldwin, E. T., Harris, M. S., Yem, A. W., Wolfe, C. L., Vosters, A. F., Curry, K. A., Murray, R. W., Bock, J. H., MARSHALL, V. P., Cialdella, J. I., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202750200 · Cited by 45
Protein crystallography and infectious diseases
Verlinde, C. L. M. J., Merritt, E. A., van den Akker, F., Kim, H., Feil, I., Delboni, L. F., Mande, S. C., Sarfaty, S., Pétra, P. H., & Hol, W. G. J. (1994) · Protein Science · doi:10.1002/pro.5560031006 · Cited by 45
Screening an Inverted Peptide Library in Water with a Guanidinium-Based Tweezer Receptor
Davies, M., Bonnat, M., Guillier, F., Kilburn, J., & Bradley, M. (1998) · The Journal of Organic Chemistry · doi:10.1021/jo981741+ · Cited by 45
Application of sequence-based methods in human microbial ecologyPreprint
Weng, L., Rubin, E. M., & Bristow, J. D. (2006) · Genome Research · doi:10.1101/gr.3676406 · Cited by 44
“Clinical practice has long favored the use of antibiotics to cover the organisms most likely to be present when infection is suspected, but this practice has contributed greatly to the spread of antibiotic resistance (Neu 1992; Cohen 2000).”
Background
Novel and Recent Synthesis and Applications of β-Lactams
Troisi, L., Granito, C., & Pindinelli, E. (2010) · Topics in heterocyclic chemistry · doi:10.1007/7081_2009_12 · Cited by 44
Differential Binding of Co(II) and Zn(II) to Metallo-β-Lactamase Bla2 from Bacillus anthracis
Hawk, M. J., Breece, R. M., Hajdin, C. E., Bender, K. M., Hu, Z., Costello, A. L., Bennett, B., Tierney, D. L., & Crowder, M. W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900296u · Cited by 44
High Level QM/MM Modeling of the Formation of the Tetrahedral Intermediate in the Acylation of Wild Type and K73A Mutant TEM-1 Class A β-Lactamase
Hermann, J. C., Pradon, J., Harvey, J. N., & Mulholland, A. J. (2009) · The Journal of Physical Chemistry A · doi:10.1021/jp9037254 · Cited by 44
Bacterial filamentation accelerates colonization of adhesive spots embedded in biopassive surfaces
Moeller, J., Emge, P., Vizcarra, I. A., Kollmannsberger, P., & Viola Vogel, B. (2013) · New Journal of Physics · doi:10.1088/1367-2630/15/12/125016 · Cited by 44
Antibiotic Binding to Dizinc β-Lactamase L1 from Stenotrophomonas maltophilia: SCC-DFTB/CHARMM and DFT Studies
Xu, D., Guo, H., & Cui, Q. (2007) · The Journal of Physical Chemistry A · doi:10.1021/jp068746s · Cited by 44
Outpatient prescription practices in rural township health centers in Sichuan Province, China
Jiang, Q., Yu, B. N., Ying, G.-Y., Liao, J., Gan, H., Blanchard, J., & Zhang, J. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-324 · Cited by 44
“Nevertheless, there was wide consensus that the number of antibiotics per encounter should be controlled within two or three [13-15].”
Background
Enhanced Loading and Controlled Release of Antibiotics Using Nucleic Acids As an Antibiotic-Binding Effector in Hydrogels
Zhang, X., Soontornworajit, B., Zhang, Z., Chen, N., & Wang, Y. (2012) · Biomacromolecules · doi:10.1021/bm3006227 · Cited by 45
Post-fabrication QAC-functionalized thermoplastic polyurethane for contact-killing catheter applications
Zander, Z. K., Chen, P., Hsu, Y., Dreger, N. Z., Savariau, L., McRoy, W. C., Cerchiari, A. E., Chambers, S. D., Barton, H. A., & Becker, M. L. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.010 · Cited by 43
The effect of four medicinal plants on the performance, blood biochemical traits and ileal microflora of broiler chicks.
Sharifi, S. D., Khorsandi, S. H., Khadem, A. A., Salehi, A., & Moslehi, H. (2013) · Hrčak Portal of scientific journals of Croatia (University Computing Centre) · Cited by 44
Minimum inhibitory concentrations of Staphylococcus aureus recovered from clinical and subclinical cases of bovine mastitis
Oliveira, L., Langoni, H., Hulland, C., & Ruegg, P. L. (2012) · Journal of Dairy Science · doi:10.3168/jds.2011-4938 · Cited by 44
“…resistant to a specific class of antimicrobial due a lack of binding sites or other pharmacological characteristics, or bacteria may acquire resistance to antimicrobials either by mutations in their chromosomal genes or by exchange of genetic material via plasmids or transposons (Neu, 1992).”
Background
Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997–2001
Ciesla, G. N., Leader, S., & Stoddard, J. J. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.03.021 · Cited by 44
“4,5 In addition, widespread antibiotic overuse has been shown to carry with it substantial cost implications.”
Background
Detection of Antimicrobial Activity in Urine for Epidemiologic Studies of Antibiotic Use
Liu, Y., Huang, W.-K., Huang, T.-S., & Kunin, C. M. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00027-x · Cited by 44
Selective Growth Inhibitory Effect of Biochanin A Against Intestinal Tract Colonizing Bacteria
Leuner, O., Flesar, J., Kokoška, L., Vlková, E., Halamová, K., & Jan, M. (2010) · Molecules · doi:10.3390/molecules15031270 · Cited by 44
“The search for a new ATB treatment may not be the most effective strategy for treating CADs because most ATB’s share the risk of ATB-resistance [21], and can perturb the gut microbiota [22], which is a well-balanced ecosystem belonging to the immune complex [4].”
Background
Viral load is a negative predictor of antioxidant levels in hepatitis C patients
Grønbæk, K., Sonne, J., Ring‐Larsen, H., Poulsen, H. E., Friis, H., & Krarup, H. B. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021027 · Cited by 43
Dipolar Cycloaddition of Novel 6-(Nitrileoxidomethyl) Penam Sulfone: An Efficient Route to a New Class of β-Lactamase Inhibitors
Sandanayaka, V. P., & Yang, Y. (2000) · Organic Letters · doi:10.1021/ol006256r · Cited by 44
A Convergent, Enantioselective Total Synthesis of Streptogramin Antibiotic (−)-Madumycin II
Ghosh, A. K., & Liu, W. (1997) · The Journal of Organic Chemistry · doi:10.1021/jo971616i · Cited by 44
NB2001, a Novel Antibacterial Agent with Broad-Spectrum Activity and Enhanced Potency against β-Lactamase-Producing Strains
Li, Q., Lee, J. Y., Castillo, R. S., Hixon, M. S., Pujol, C. J., Doppalapudi, V. R., Shepard, H. M., Wahl, G. M., Lobl, T. J., & Chan, M. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1262-1268.2002 · Cited by 44
“(24), such as cell wall synthesis, protein synthesis, or DNA gyrase.”
Background
Approaches to Limiting Emergence of Antimicrobial Resistance in Bacteria in Human Populations
Hughes, J. M., & Tenover, F. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s131 · Cited by 44
“The definition of emerging infectious diseases in the Institute of Medicine report includes drug-resistant infections, which have been on the upsurge for several years [13-15].”
Background
A biomimetic peptide–drug supramolecular hydrogel as eyedrops enables controlled release of ophthalmic drugs
Pan, M., Ren, Z., Ma, X., Chen, L., Lv, G., Liu, X., Li, S., Li, X., & Wang, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.06.036 · Cited by 43
Inactivated whole-cell bacterial vaccines: current status and novel strategies
Pace, J., Rossi, H. A., Esposito, V. M., Frey, S. M., Tucker, K. D., & Walker, R. I. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00046-2 · Cited by 43
State of diagnosing infectious pathogens using colloidal nanomaterials
Kim, J., Mohamed, M. A. A., Zagorovsky, K., & Chan, W. C. W. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.013 · Cited by 44
“However, IDs also cannot be overlooked in the developed world due to the rapid evolution of antimicrobial resistance that render antibiotics less effective against these infections [9, 10] .”
Background
Enhanced antibacterial activity of silver-decorated sandwich-like mesoporous silica/reduced graphene oxide nanosheets through photothermal effect
Liu, R., Wang, X., Ye, J., Xue, X., Zhang, F., Zhang, H., Hou, X., Liu, X., & Zhang, Y. (2018) · Nanotechnology · doi:10.1088/1361-6528/aaa624 · Cited by 43
Fungal Metabolites Antagonists towards Plant Pests and Human Pathogens: Structure-Activity Relationship Studies
Masi, M., Nocera, P., Reveglia, P., Cimmino, A., & Evidente, A. (2018) · Molecules · doi:10.3390/molecules23040834 · Cited by 43

Authors: Neu, H. C.
Affiliations: Columbia University (US)
Corresponding author: Neu, Harold C.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1992-08-21
Volume: 257
Issue: 5073
Pages: 1064-1073
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.257.5073.1064
OpenAlex: W1980595924
Cited by: 2,834
References: 109
Citations by year: 2026: 23 · 2025: 48 · 2024: 57 · 2023: 71 · 2022: 91 · 2021: 93 · 2020: 123 · 2019: 100 · 2018: 122 · 2017: 123 · 2016: 105 · 2015: 87 · 2014: 95 · 2013: 109 · 2012: 99
FWCI: 46.70
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords: antibiotic resistance, bacterial resistance, plasmids, transposable elements, horizontal gene transfer, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus, Enterobacteriaceae, Pseudomonas, antibiotic overuse, hygiene, novel antimicrobial agents
MeSH terms: Anti-Bacterial Agents, Bacterial Infections, Cross Infection, Drug Resistance, Microbial, Enterobacteriaceae, Haemophilus influenzae, Humans, Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Crisis in Antibiotic Resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks